The clinical research landscape in Canada is undergoing its most significant transformation in decades. With Health Canada’s adoption of ICH E6(R3) effective April 1, 2026, the regulatory expectations for Good Clinical Practice (GCP) have evolved dramatically. If you are involved in clinical trials in Canada—whether as a sponsor, investigator, research coordinator, or CRO professional—you need to be prepared.
Our comprehensive Health Canada Good Clinical Practice (GCP) Training program is designed to equip you with the knowledge and practical skills required to conduct clinical trials in full compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the new ICH E6(R3) guideline.
Why Health Canada GCP Training Matters Now
Health Canada has fully adopted ICH E6(R3) as the standard for GCP in Canada. This update introduces key concepts that fundamentally change how clinical trials should be designed, conducted, and monitored:
- Quality by Design (QbD): Quality must be built into the scientific and operational design of clinical trials from the outset.
- Proportionality: Trial procedures, oversight, and documentation should be scaled according to the risk, complexity, and context of the study.
- Fitness-for-Purpose: Not all data may need to be verified, as long as the conclusions drawn are valid and reliable.
- Data Governance: New requirements for appropriate management of data integrity, traceability, and security throughout the data life cycle.
Health Canada provided a six-month implementation period running to September 30, 2026, with full compliance expected from October 1, 2026. This means organizations and individuals must act now to update their knowledge and processes.
Critical Update: GCP re-training is now mandatory for researchers and research team members conducting Health Canada-regulated clinical trials. Many sponsors are already requiring updated GCP training before April 1, 2026.
What Our Health Canada GCP Training Covers
Our comprehensive self-study program provides complete coverage of all regulatory requirements and practical skills needed for clinical trial conduct in Canada. The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026.
Module 1: Introduction to Health Canada GCP
- Health Canada clinical trial regulatory framework
- Part C, Division 5 of the Food and Drug Regulations
- ICH E6(R3) overview and key changes
- Roles of Health Canada, REBs, Sponsors, and Investigators
Module 2: Ethical Principles and Protection of Participants
- Declaration of Helsinki and ethical foundations
- Rights, safety, and well-being of participants
- Vulnerable populations and special protections
- Participant confidentiality and privacy
Module 3: Roles and Responsibilities
- Complete sponsor responsibilities under C.05.010
- Qualified Investigator (QI) requirements and delegation
- Clinical research staff and CRO responsibilities
- Training and competency requirements
Module 4: Clinical Trial Lifecycle
- Clinical trial phases (I through IV)
- Clinical Trial Application (CTA) process
- REB approval and site initiation
- Monitoring, close-out, and archiving
Module 5: Protocol Compliance and Documentation
- Protocol development and amendments
- Protocol deviations and violations
- Essential documents, Trial Master File (TMF), and Investigator Site File (ISF)
- Investigator Brochure and Standard Operating Procedures (SOPs)
Module 6: Informed Consent Process
- Regulatory requirements and consent documentation
- Consent updates and re-consent
- Assent, emergency consent, and withdrawal of consent
- Documentation best practices
Module 7: Investigational Product (IP) Management
- IP accountability, receipt, and storage
- Temperature monitoring and excursions
- Dispensing, returns, and destruction
- Randomization and blinding procedures
Module 8: Clinical Data Management and Documentation
- Source documentation and ALCOA+ principles
- Electronic Data Capture (EDC) systems
- Data integrity, corrections, and audit trails
- Record retention requirements
Module 9: Safety Reporting
- Adverse Events (AEs) and Serious Adverse Events (SAEs)
- Adverse Drug Reactions (ADRs) and SUSARs
- Reporting timelines and requirements
- Annual safety reporting and pharmacovigilance
Module 10: Quality Management and Risk-Based Monitoring
- Quality Management Systems and Quality by Design
- Risk assessment and mitigation
- Risk-Based Monitoring (RBM) approaches
- Remote and centralized monitoring
Module 11: Clinical Trial Inspections and Enforcement
- Health Canada GCP inspection process
- Risk classification of findings
- Corrective and Preventive Actions (CAPA)
- Inspection readiness and enforcement actions
Module 12-17: Advanced Topics
- Clinical Trial Applications and Amendments
- Investigational Product Quality and GMP
- Investigator Brochure and Reference Safety Information
- Protocol Development
- Clinical Study Reports and Publication
- Record Keeping and Archiving
Who Should Enroll?
This training is essential for all individuals and organizations involved in the conduct of clinical trials of drugs in human participants in Canada:
| Role | Key Responsibility |
|---|---|
| Sponsors (commercial and academic) | Overall trial responsibility and regulatory compliance |
| Qualified Investigators (QIs) | Site-level conduct and participant safety |
| REB Members and Administrators | Ethical oversight and participant protection |
| Clinical Research Coordinators | Day-to-day trial activities and documentation |
| CROs and Service Providers | Delegated trial activities and quality management |
| Clinical Monitors and Auditors | Oversight and compliance verification |
| Pharmacovigilance Professionals | Safety monitoring and reporting |
| Regulatory Affairs Professionals | Submissions and regulatory compliance |
| Data Managers and Biostatisticians | Data integrity and analysis |
Certification Details
Upon successful completion of this training program, participants will receive a certificate of completion documenting their understanding of Health Canada GCP requirements.
Certification Requirements:
- Complete all 17 training modules
- Achieve a passing score of 80% or higher on the cumulative final assessment
- Complete all module knowledge checks and case study exercises
Training Records:
- Downloadable certificates provided
- Records of completion maintained for organizational audit and inspection purposes
Health Canada Inspection Findings: What You Need to Know
Health Canada GCP inspections consistently identify deficiencies in basic documentation, particularly training records. The most common findings include:
- Source documentation deficiencies (ALCOA+ principles not followed)
- Informed consent issues (missing or outdated consent forms)
- Investigational product accountability failures (incomplete records)
- Safety reporting delays (SAEs not reported within 24 hours)
- Inadequate training documentation
Our training program addresses these common inspection findings head-on, ensuring you and your organization are prepared for regulatory scrutiny.
Why Choose GxP Trainings?
- Regulatory Alignment: Our curriculum is fully aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026
- Comprehensive Coverage: 17 modules covering all aspects of GCP in the Canadian context
- Practical Focus: Case studies, worked examples, and scenario-based exercises
- Expert-Developed: Content built upon authoritative regulatory and guidance documents
- Flexible Learning: Self-study format that fits your schedule
- Verifiable Certification: Recognized certificate with 2-year validity
Take Action Today
With the October 1, 2026 full compliance deadline approaching, now is the time to ensure you and your team are fully prepared for the new regulatory landscape. GCP re-training is mandatory, and organizations that fail to update their knowledge risk inspection findings, enforcement actions, and compromised participant safety.
Don’t wait until it’s too late. Enroll in the Health Canada Good Clinical Practice (GCP) Training program today and ensure your clinical trials meet the highest standards of quality, safety, and regulatory compliance.
👉 Enroll Now: Health Canada Good Clinical Practice (GCP) Training 👈
Author
